Speakers: Natalie Jackson, RN, MSN, CRNP and Suzanne McGettigan, MSN, CRNP, AOCN
Checkpoint inhibitors are being used for a growing number of oncologic indications. As we learn more about these agents, we learn more about their associated adverse events. Endocrine and rheumatologic adverse events are well documented, and clinicians need to be well-versed in their assessment, diagnosis, and management. This webinar provides an overview of endocrine and rheumatologic immune-related adverse events, their assessment and grading, as well as management and practice pearls.
Take the evaluation to earn .5 contact hours of CNE.